Ferring’s low-volume bowel prep now available in the US — 4 insights

Ferring Pharmaceuticals’ low-volume bowel preparation Clenpiq is now available in the U.S. via prescription.

Advertisement

Here’s what you should know:

1. Clenpiq bowel prep is prescribed ready to drink.

2. The prep received FDA approval in November 2017.

3. New York City-based NYU Langone Health Clinical Professor of Medicine Jonathan Cohen, MD, said, “A safe, effective and well-tolerated bowel prep is an important step towards a successful colonoscopy. Patients now have the option of a ready-to-drink, low volume bowel prep.”

4. Ferring’s CEO Paul Navarre said the bowel prep will strengthen the company’s U.S. portfolio.

More articles on gastroenterology: 
Regent Surgical Health opens new joint venture ASC & more — 6 ASC company key notes
All 71 new 2017 ASCs by specialty
14 key points on total joint replacements in ASCs for 2018

Advertisement

Next Up in GI & Endoscopy

Advertisement

Comments are closed.